Accounts Payable

6 Months Ended

Jun. 30, 2013

Accounts Payable Disclosure [Abstract]

Accounts Payable

4. Accounts Payable

As of June 30, 2013, Current Liabilities included accounts payable of $165,897 comprised primarily of approximate amounts owed to the Company’s drug contract manufacturers totaling $114,200, $13,900 to several companies involved in research and development testing, $6,800 in fees for an industry conference at which the Company will be making a corporate presentation, $6,000 to outside consultants and $15,900 to the Company’s attorneys and auditors. As of June 30, 2013 Current Liabilities included accounts payable related party totaling $10,017 comprised of Technology License patent maintenance fees. (See Note 2.). As of December 31, 2012, Current Liabilities included accounts payable $57,000 and accounts payable related party of $8,582, which amounts were subsequently paid in 2013.